Insider track record
OtherAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by MAHONEY DAVID L. Officer active across 3 companies, notably Corcept Therapeutics INC. Aggregated, 13 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €284k. Activity tracked since 11 May 2021. The latest transaction was filed on 16 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations13 total
30,000 shares@ US$6.5519.8% of flowCommon StockSEC:0000950170-25-075470:0
30,000 shares@ US$1.745.5% of flowCommon StockSEC:0000950170-24-044185:0
17,420 shares0Common StockSEC:0000950170-23-045848:0
10,000 shares@ US$30.946732.0% of flowCommon StockSEC:0000950170-23-043043:0
30,000 shares@ US$1.745.4% of flowCommon StockSEC:0000899243-23-012472:0
30,000 shares@ US$4.050.0019% mcap34.1% of flowCommon StockSEC:0000899243-22-020211:0
30,000 shares@ US$4.420.0018% mcap32.9% of flowCommon StockSEC:0000899243-22-011615:0
5,000 sharesCommon StockSEC:0001328143-21-000094
5,000 sharesCommon StockSEC:0001328143-21-000094:0
5,000 shares0Common StockSEC:0001328143-21-000059:0
5,000 shares0Common StockSEC:0001328143-21-000059
30,000 shares@ US$4.42100.0% of flowCommon StockSEC:0000899243-21-019425
30,000 shares@ US$4.420.0018% mcap32.9% of flowCommon StockSEC:0000899243-21-019425:0
About MAHONEY DAVID L
David L Mahoney is a director at Corcept Therapeutics INC and has also filed at Adamas Pharmaceuticals Inc and CORCEPT THERAPEUTICS INC.